Ensign Peak Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Buy |
|
|||||
|
2025
Q1 | $1.75M | Buy |
|
|||||
|
2024
Q4 | $1.23M | Hold |
|
|||||
|
2024
Q3 | $1.31M | Hold |
|
|||||
|
2024
Q2 | $1.17M | Hold |
|
|||||
|
2024
Q1 | $1.16M | Sell |
|
|||||
|
2023
Q4 | $1.22M | Hold |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $794K | Buy |
|
|||||
|
2023
Q1 | $614K | Buy |
|
|||||
|
2022
Q4 | $725K | Buy |
|
|||||
|
2022
Q3 | $386K | Sell |
|
|||||
|
2022
Q2 | $434K | Hold |
|
|||||
|
2022
Q1 | $469K | Hold |
|
|||||
|
2021
Q4 | $428K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $782K | Sell |
|
|||||
|
2021
Q1 | $1.02M | Hold |
|
|||||
|
2020
Q4 | $1.47M | Hold |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|
|||||
|
2020
Q2 | $597K | Hold |
|
|||||
|
2020
Q1 | $427K | Buy |
|